Indian Journal of Medical Biochemistry

Register      Login

VOLUME 25 , ISSUE 2 ( May-August, 2021 ) > List of Articles

Original Article

Study of Levels of Free Testosterone in Patients with Acne Vulgaris before and after Treatment

Navjot Bajwa, Sunil K Gupta, Abhra Ghosh, Manraj Kaur

Keywords : Acne, anti-androgen therapy, Free testosterone

Citation Information : Bajwa N, Gupta SK, Ghosh A, Kaur M. Study of Levels of Free Testosterone in Patients with Acne Vulgaris before and after Treatment. Indian J Med Biochem 2021; 25 (2):47-50.

DOI: 10.5005/jp-journals-10054-0175

License: CC BY-NC 4.0

Published Online: 29-10-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Background: Acne vulgaris is one of the most common diseases afflicting humans and it is the skin disease most commonly treated by physicians. The prevalence of acne is about 15% in all age-groups and it is seen more frequently in women than men. Abnormal follicular differentiation, increased cornification, enhanced sebaceous gland activity, hyperseborrhea, bacterial hypercolonization, as well as inflammation and immunological host reaction are the major contributors to acne formation. Other factors such as diet, exposure to the sun, poor hygiene, stress, and genetics are believed to cause or worsen acne symptoms. Hormonal imbalance also plays a role in acnegenesis. Out of all the hormones, androgens are thought to be most important due to its association with the follicular and sebaceous glands. Aim and objective: Our aim of the study is to compare the severity of acne vulgaris with free testosterone levels and to correlate its level before and after treatment. Ninety-three patients attending OPD of the Department of Dermatology, Venereology and Leprosy of Dayanand Medical College and Hospital, Ludhiana, were enrolled in the study period of 1 year. Results: The mean free testosterone levels before treatment were 1.58 ± 1.50 pg/mL and after treatment were 1.34 ± 0.90 pg/mL. These values were statistically significant (p = 0.006). The mean free testosterone levels in the age-group of <20 years before treatment were 1.93 ± 1.65 pg/mL and after treatment were 1.61 ± 1.06 pg/mL. These values were statistically significant (p = 0.016). Conclusion: The increase in free testosterone levels may be responsible as one of the factors for the development of acne vulgaris. Clinical significance: As free testosterone is associated with acne vulgaris, free testosterone levels should be measured in patients presenting with acne vulgaris, especially in the age-group 15–30 years and treatment-resistant cases and anti-androgen treatment may be indicated in cases with elevated free testosterone levels.

  1. Gelmetti CC, Krowchuk DP, Lucky AW. Acne. In: Schachner LA, Katz SI, ed. Pediatric dermatology. 3rd ed., Philadelphia: Mosbly; 2003. pp. 589–609.
  2. Galobardes B, Davey Smith G, Jefferys M, et al. Has acne increased? Prevalence of acne history among university students between 1948 and 1968. The glaskow alumni cohort study. Br J Dermatol 2005;152(4):824–825. DOI: 10.1111/j.1365-2133.2005.06527.x.
  3. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol 1999;41(4):577–580. DOI: 10.1016/S0190-9622(99)70300-2.
  4. Dalgard F, Svensson A, Holm JO, et al. Self-repoted skin morbidity in Oslo: associations with sociodemographic factors among adult in across-sectional study. Br J Dermatol 2004;151(2):452–457. DOI: 10.1111/j.1365-2133.2004.06058.x.
  5. Perkins AC, Maglione J, Hillebrand GG, et al. Acne vulgaris in women: prevalence across the life span. J Women Health 2012;21(2):223–230. DOI: 10.1089/jwh.2010.2722.
  6. Simpson NB, Cunliffe WJ. Disorders of sebaceous glands. In: Burns T, Breathnach S, Cox N, et al., ed. Rook's textbook of dermatology. 7th ed., Oxford: Blackwell Publishing; 2004. p. 43.1–43.75.
  7. Bakry OA, El Shazly RM, El Farargy SM, et al. Role of hormones and blood lipids in the pathogenesis of acne vulgaris in non-obese, non-hirsute females. Indian Dermatol Online J 2014;5(Suppl 1):S9–S16. DOI: 10.4103/2229-5178.144506.
  8. Pillsbury DM, Shelley WB, Klingman AM. Dermatology. Philadelphia: WB Saunders; 1956. p. 180.
  9. Slayden SM, Moran C, Sams WM, et al. Hyperandrogenemia in patients preventing with acne. Fertil Steril 2001;75(5):889–892. DOI: 10.1016/s0015-0282(01)01701-0.
  10. Rahman MM, Sikder MA, Rashid MM, et al. Association of serum testosterone with acne vulgaris in women. Bangabandhu Sheikh Mujib Med Univ J 2012;5(1):1–5. DOI: 10.3329/bsmmuj.v5i1.10980.
  11. Hamilton J, Terada H, Mestler GE. Greater tendency to acne in white Americans than in Japanese populations. J Clin Endocrinol 1961;24(3):267–272. DOI: 10.1210/jcem-24-3-267.
  12. Burton JL, Cunliffe WJ, Stafford I, et al. The prevalence of acne vulgaris in adolescence. Br J Dermatol 1971;85(2):119–126. DOI: 10.1111/j.1365-2133.1971.tb07195.x.
  13. Lasnitzki I, Franklin HR. The influence of serum on uptake, conversion and action of testosterone in rat prostate glands in organ culture. J Endocrinol 1972;54(2):333. DOI: 10.1677/joe.0.0540333.
  14. Van der Meeren HL, Thijssen JH. Circulating androgens in male acne. Br J Dermatol 1984;110(5):609–611. DOI: 10.1111/j.1365-2133.1984.tb04686.x.
  15. Lucky AW, Biro FM, Simbartl LA, et al. Predictors of severity of acne vulgaris in young adolescent girls: results of a five-year longitudinal study. J Pediatr 1997;130(1):30–39. DOI: 10.1016/s0022-3476(97)70307-x.
  16. Anderson DC. Sex hormone binding globulin. Clin Endocrinol 1974;3(1):69–96. DOI: 10.1111/j.1365-2265.1974.tb03298.x.
  17. Lawrence D, Shaw M, Katz M. Elevated free testosterone concentration in men and women with acne vulgaris. Clin Exp Dermatolo 1986;11(3):263–273. DOI: 10.1111/j.1365-2230.1986.tb00458.x.
  18. Kushlinskii NE, Salamova IV, Masyukova SA, et al. Sex hormone binding globulin, serum testosterone and androgen receptors in the skin in papulopustular and conglobata forms of acne vulgaris. Bull Exp Biol Med 1997;123(2):163–165. DOI: 10.1007/BF02766441.
  19. Gollnick H, Cunliffe W. Management of acne. J Am Acad Dermatol 2003;41(1 Suppl):S1–S38. DOI: 10.1067/mjd.2003.618.
  20. Baumann M. Cosmetic dermatology principles and practice. New York: The McGraw-Hill Companies; 2002.
  21. Hatwal A, Singh SK, Agarwal UK, et al. Serum testosterone, DHEA-S and androstenedione levels in acne. Indian J Dermatol Venereol Leprol 1990;56:427–429.
  22. Held BL, Nader S, Rigau LJR, et al. Acne and hyperandrogenism. J Am Acad Dermatol 1984;10(2 Pt 1):223–226. DOI: 10.1016/s0190-9622(84)70026-0.
  23. Sultan CH, Oliel V, Audran F, et al. Free and total plasma testosterone in men and women with acne. Acta Derm Venereol 1986;66(4):301–304.
  24. Förström L, Mustakallio KK, Dessypris A, et al. Plasma testosterone levels and acne. Acta Derm Venereol 1974;54(5):369–371.
  25. Clibula D, Hill M, Vohradnikova O, et al. The role of androgens in determining acne severity in adult women. Br J Dermatol 2000;143(2):399–404. DOI: 10.1046/j.1365-2133.2000.03669.x.
  26. Feily A, Taheri T, Meier-Schiesser B, et al. The effect of low-dose isotretinoin therapy on serum androgen levels in women with acne vulgaris. Int J Womens Dermatol 2019;6(2):102–104. DOI: 10.1016/j.ijwd.2019.10.007.
  27. Paulson JD, Keller DW, Wiest WG, et al. Free testosterone concentration in serum: Elevation is the hallmark of hirsutism. Am J Obstet Gynecol 1977;128(8):851–857. DOI: 10.1016/0002-9378(77)90052-7.
  28. Vermeulen A, Stoica T, Verdonck L. The apparent free testosterone concentration: an index of androgenicity. J Clin Endocrinol Metabol 1971;33(5):759–767. DOI: 10.1210/jcem-33-5-759.
  29. Rosenfield RL. Plasma testosterone binding globulin and indices of the concentration of unbound plasma androgens in normal and hirsute subjects. J Clin Endocrinol Metabol 1971;32(6):717–728. DOI: 10.1210/jcem-32-6-717.
  30. Darley CR, Moore JW, Besser GM. Androgen status in women with acne vulgaris. Br J Dermatol 1980;103(Suppl 18):17.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.